Skip to main content

BlackRock, Inc.

Position in LLY — ELI LILLY & Co

CIK 2012383 New York, NY

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$61,055,107,035
-$10,725,853,641 QoQ
Shares Held
66,380,842
-0.6% QoQ
Ownership
7.05%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 90.09302111594185.ToString("F0")% Shared 0.ToString("F0")% None 9.906978884058145.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Mar 31, 2026
CallValue
$103,934,010
CallShares
113,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $235,197,977,777 across 20 Drug Manufacturers - General names. LLY ranks #1 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
66,380,842 $61,055,107,035

All Filings in LLY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $103,934,010 113,000
2026-03-31 $61,055,107,035 66,380,842
2025-12-31 $71,780,960,676 66,792,863
2025-09-30 $50,212,849,169 65,809,763
2025-06-30 $51,419,093,587 65,961,661
2025-06-30 $74,367,162 95,400
2025-03-31 $54,255,657,407 65,691,973
2025-03-31 $32,375,672 39,200
2024-12-31 $50,356,876,008 65,229,114
2024-09-30 $57,002,379,814 64,341,129